FIELD: medicine.
SUBSTANCE: invention refers to a visualising agent for visualisation of cell oxidative stress in vivo and a precursor compound for a synthesis of the visualising agent. The agent contains a tagged cystine compound having a structure I: wherein one of R and R' contains a tag specified in a fluorescent tag representing Bodipy, or a radioactive tracer specified in 11C, 13N, 15O, 17F, 18F, 75Br, 76Br, 124I, 123I, 131I and 77Br, and the other of R and R' represents hydrogen. Also, the invention refers to a method for visualising a biological sample having a cystine/glutamate transporter with the method involving administering the above visualising agent into the above biological sample through the cystine/glutamate transporter.
EFFECT: invention provides the method for detecting oxidative stress in vivo in apoptotic cells by administering the visualising agent in a cystine/glutamate cell antiporter.
14 cl, 10 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ISATIN DERIVATIVES APPLICABLE AS IMAGING IN VIVO AGENTS | 2009 |
|
RU2535975C2 |
CELLULAR SYSTEM FOR TARGETED DELIVERY OF A PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL | 2016 |
|
RU2771323C2 |
PEPTIDE COMPOSITION OF RADIOACTIVE INDICATORS | 2011 |
|
RU2594167C2 |
RADIOACTIVE LABELLED PEPTIDES BINDING TO HER2 | 2011 |
|
RU2592685C2 |
USEFUL LOAD DELIVERY TO STEM CELLS | 2018 |
|
RU2795155C1 |
RADIOPHARMACEUTICAL PRODUCTS | 2007 |
|
RU2448733C2 |
SYNTHESIS METHOD | 2011 |
|
RU2572554C2 |
METHODS OF DETECTING 5T4-POSITIVE CIRCULATING TUMOR CELLS AND METHODS OF DIAGNOSTICS OF 5T4-POSITIVE CANCER IN MAMMALS | 2013 |
|
RU2646498C2 |
VISUALISATION TECHNIQUE | 2008 |
|
RU2505316C2 |
PSMA-BINDING AGENTS AND USING THEM | 2009 |
|
RU2494096C2 |
Authors
Dates
2014-07-20—Published
2010-04-27—Filed